Lawrence F. Eichenfield
Independent DirectorDr. Lawrence F. Eichenfield, M.D., FAAD, serves as the Chairman of Scientific Advisory Board at ASLAN Pharmaceuticals Limited since September 2021. He has been Member of Advisory Board at Lipidio Pharmaceuticals Inc. since 2022 and serves as its Chair of Scientific Advisory Board. Dr. Eichenfield was co-founder and Chair of the Pediatric Dermatology Research Alliance (PeDRA). He has been Member of Scientific Advisory Board at ASLAN Pharmaceuticals Pte. Ltd. since March 2022. He served as Director at Forte Biosciences, Inc. since June 2020 until September 17, 2024 and served as its Member of Scientific Advisory Board. Dr. Eichenfield serves as Clinical Professor in the departments of pediatrics and medicine (dermatology) at the University of California-San Diego School of Medicine. Dr. Eichenfield served as Chairman of Advisory Board at Novan, Inc. Dr. Eichenfield serves as an Editor-in-chief of Pediatric Dermatology. He served as Member of Scientific Advisory Board at Verrica Pharmaceuticals Inc. since October 2019 and serves as its Independent Director since July 2020. He was a Scientific Advisor of Arcutis Biotherapeutics, Inc. (Formerly known as Arcutis Inc.) He serves as the Chief of Pediatric and Adolescent Dermatology at Rady Children's Hospital, San Diego. He serves as Principal Investigator in numerous trials of topical and systemic agents for conditions including atopic dermatitis, fungal infections, acne and many others in addition, he served as the President of the Society for Pediatric Dermatology. His clinical interests include a topic dermatitis, acne, laser surgery and procedural pain control. An Active Member of the AAD, he has served as the Chairman of the consensus conference on pediatric a topic dermatitis. He serves as a Director at American Academy of Dermatology. He has been honored as a Member of the Alpha Omega Alpha Honor Society during medical school and as a recipient of the Benjamin Ritter Award at Children’s Hospital of Philadelphia and excellence in teaching awards from UC San Diego Pediatrics, UC San Diego Dermatology and Rady Children’s Hospital-San Diego. He served as a Member of Scientific Advisory Board at Celsus Therapeutics Plc. He serves as a Member of Scientific Advisory Board of Ansata Therapeutics, Inc. He serves as a Member of the Medical Advisory Board of Ivrea Pharmaceuticals, Inc. He has appeared in front of FDA advisory boards. He was a Pediatric Resident and Chief Resident at Children's Hospital of Philadelphia and completed dermatology training at the Hospital of the University of Pennsylvania. He has published more than 150 journal articles, chapters and abstracts and books. He is Board certified in pediatrics, dermatology and pediatric dermatology. Dr. Eichenfield earned his Medical Degree from Mount Sinai School of Medicine.
Positions
- Company NameVerrica Pharmaceuticals Inc.Stock CodeVRCAPositionIndependent DirectorColleagues
- JMJayson M. RiegerPresident, CEO & Director
- PBPaul B. ManningChairman of the Board
- JJJohn J. KirbyInterim Chief Financial Officer
- NLNoah L. RosenbergChief Medical Officer
- DZDavid ZawitzCOO, Chief Legal Officer & Secretary
- ESEugene ScavolaExecutive Vice President of Technical Operations
- MAMark A. PrygockiIndependent Director
- DNDiem NguyenIndependent Director
